Spyre Therapeutics Announces Pricing of $275.0 Million Public Offering of Common Stock
WALTHAM, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre”…
Jefferies Provides Letter from Its CEO and President Regarding Point Bonita Capital and First Brands Group
NEW YORK--(BUSINESS WIRE)--Jefferies Financial Group, Inc. (NYSE: JEF) (“Jefferies”) announced today that…
RadNet, Inc. to Present at the Jefferies Healthcare Services Conference on September 29, 2025
September 26, 2025 06:00 ET Â | Source: RadNet, Inc. LOS ANGELES, Sept.…